Search - tctmd.com

Displaying 261 - 280 of 382

Sort: Relevancy | Date

Presentation TCT 2016

Why Is Post-Dilatation Mandatory? Technical And Clinical Considerations (With Case Examples)

Presenter: Jonathan M. Hill, Christoph K. Naber, Azeem Latib

November 01, 2016

Presentation TCT 2016

If You Do Image, Which Is The Tool For BRS - IVUS, HD-IVUS, Or OCT?

Presenter: Jonathan M. Hill, Christoph K. Naber, Carlo Di Mario

November 01, 2016

Presentation TCT 2016

Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine!

Presenter: Jonathan M. Hill, Christoph K. Naber, Ricardo A. Costa

November 01, 2016

Presentation TCT 2016

Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective!

Presenter: Jonathan M. Hill, Christoph K. Naber, Joanna J. Wykrzykowska

November 01, 2016

Presentation TCT 2016

Can QCA Be Trusted? Insights From OCT and More

Presenter: Jonathan M. Hill, Christoph K. Naber, Yoshinobu Onuma

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: PLATINUM DIVERSITY

Presenter: Philip M. Urban, Stephen G. Worthley, Bonnie H. Weiner

November 01, 2016

Presentation TCT 2016

BRS Sizing Considerations: Eyeball, Catheter or Inflated Balloon Guidance, QCA or Intracoronary Imaging (With Case Examples)?

Presenter: Jonathan M. Hill, Christoph K. Naber, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

Lesion Preparation: Techniques and Devices, A Lesion-Specific Approach (With Case Examples)

Presenter: Jonathan M. Hill, Christoph K. Naber, Corrado Tamburino

November 01, 2016

Presentation TCT 2016

Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS

Presenter: Jonathan M. Hill, Christoph K. Naber, Manel Sabate

November 01, 2016

Presentation TCT 2016

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis

November 01, 2016

Presentation TCT 2016

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Presenter: Stephen G. Ellis, Patrick W. Serruys, Ron Waksman

November 01, 2016

Presentation TCT 2016

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Presenter: Stephen G. Ellis, Patrick W. Serruys, Holger M. Nef

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel

November 01, 2016

Presentation TCT 2016

A Critical Review of Technique Across the Absorb Trials

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement

Presenter: Michael C. John, Gregg W. Stone, Jason R. Weidman

November 01, 2016

Presentation TCT 2016

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

Presenter: Stephen G. Ellis, Patrick W. Serruys, David G. Rizik

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Presenter: Michael C. John, Gregg W. Stone, Chuck Simonton

November 01, 2016

Advertisement

Why Is Post-Dilatation Mandatory? Technical And Clinical Considerations (With Case Examples)

If You Do Image, Which Is The Tool For BRS - IVUS, HD-IVUS, Or OCT?

Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine!

Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective!

Can QCA Be Trusted? Insights From OCT and More

Highlights (and my Interpretations) From: PLATINUM DIVERSITY

BRS Sizing Considerations: Eyeball, Catheter or Inflated Balloon Guidance, QCA or Intracoronary Imaging (With Case Examples)?

Lesion Preparation: Techniques and Devices, A Lesion-Specific Approach (With Case Examples)

Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

A Critical Review of Technique Across the Absorb Trials

Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement

PSP: A Synthesis of Technique Imperatives for Absorb Implantation

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content